IndieBio. Our business is to turn scientists into entrepreneurs who can save lives and save the planet (we call this “human and planetary health”). It was not that long ago (2014) that IndieBio exploded on the scene. We were the first VC to put a $2 million biotech lab in our office. We were the first accelerator to systematically write small checks into radical ideas using biology as a technology to disrupt markets outside healthcare. That portfolio of companies now has a cumulative enterprise value of nearly $4 billion — despite the average company being only 3 years old. Along the way our funds have expanded, as has our reach around the world.
Industria(s) y tecnología(s) de preferencia
Biotech
Etapa de inversión
Idea
Pre-seed
Ticket mínimo
US $
275,000
Ticket máximo
US $
525,000
Modelo de negocio
Sin datos
Agnostic
Inversionista enfocado en impacto
Sin datos
No
Países donde tiene oficina
Estados Unidos de América
Región donde invierte
National, LATAM, Asia, Africa, Europe, Oceania, North America (USA and Canada)
Requerimientos especiales para invertir
Multiple co-founders
Inversiones relevantes
Beeflow, Caspr, NotCo, Michroma, Geltor, Perfect Day, Upside Foods, Mycoworks, The Every Company
¿Lideran ronda?
Sí
No
# de fondo
4
Ver podcast
Otras instituciones sugeridas
Instituciones sugeridas por la etapa en la que invierten